Exhibit
10.2


 


EMPLOYMENT AGREEMENT


 


This Employment Agreement (“Agreement”)
made and entered into effective as of the 1st day of November 2022 (the “Effective Date”) by and between Raymond F. Vennare,
an individual, residing at 179 West Hutchinson Avenue, Pittsburgh, PA 15218, and Predictive Oncology Inc., 2915 Commers Drive, Suite 900,
Eagan, Minnesota 55121, a Delaware corporation (“Company”), collectively referred to as “the Parties”.


 


WITNESSETH:


 


WHEREAS, the Company desires to employ Employee
to render services for the Company as its Chief Executive Officer on the terms and conditions hereinafter set forth, and Employee desires
to be employed by the Company on such terms and conditions;


 


NOW, THEREFORE, in consideration of the promises
and of the mutual covenants and agreements contained herein, the Parties hereby agree as follows:


 


1.                 
Employee’s Acknowledgment and Certifications. Employee hereby represents and certifies that Employee is not subject to
any other agreement or restrictive covenant that Employee violates by working with the Company. Further, Employee represents that no conflict
of interest or breach of Employee’s fiduciary duties will result by working with and performing duties for the Company. Employee
further agrees and certifies that Employee will not use or disclose to the Company any confidential, proprietary or trade secret information
belonging to another individual or entity which may not properly be used or disclosed by Employee to the Company.


 


2.                 
 Employment and Term. The Company and
Employee acknowledge that Employee has been a member of the Board of Directors of the Company since September 2021. The Company
hereby employs Employee and Employee hereby accepts employment with the Company upon the terms and conditions of this Agreement.
Employee’s employment with the Company is at-will and will commence on November 1, 2022. This Agreement does not modify the
at-will nature of Employee’s employment nor is it intended to guarantee Employee a specific term of employment with the
Company. Either Employee or the Company may terminate the employment relationship at any time, for any lawful reason. Employee
agrees to abide by all Company rules, policies, and procedures.


 


3.                  
Duties. Employee shall have the title of Chief Executive Officer and shall continue to serve as a member of the Board of Directors
in accordance with the Company’s bylaws. Employee will devote Employee’s full working time, attention, loyalty, skills and
efforts to diligently perform all the duties, responsibilities, and requirements assigned to Employee while employed by the Company. Employee
will be based out of the Company’s office in Pittsburgh, Pennsylvania and will travel on business matters to the Company’s
other offices and elsewhere at Company expense, as needed, subject to the Company’s Expense Reporting Procedure and policies, as
in effect from time to time. Employee’s title, position and duties are at all times subject to change at the Company’s sole
discretion. Employee will be limited to holding board seats for a maximum of two public companies in addition to the Company as long as
there is no conflict or interference with Employee’s obligations to the Company.


 


 






      


     


    

 


4.                  
Compensation.


 


		a.	Base Salary. Employee will receive an initial annualized base salary of $525,000 (gross, less applicable
legally required withholdings and such other deductions as Employee voluntarily authorizes in writing). Commencing November 1, 2022, Employee
will not receive additional compensation for service on the Board or committees of the Board. Employee’s base salary and other compensation
will be subject to review and adjustment by the Company at any time, as the Company deems appropriate; provided, that Employee’s
base salary will not be reduced without Employee’s consent unless a salary reduction is imposed upon substantially all employees
of the Company as part of a general reduction.
	 	 	 
	 	b.	Bonus and Incentive Compensation. For each calendar year during the
                          term of this Agreement, beginning at date of hire in 2022, Employee shall be eligible to receive an annual
                          incentive bonus determined annually at the discretion of the Compensation Committee of the Board. The Compensation
                          Committee will award a bonus based on performance of Employee vs. annual MBO/Objectives on a percentage of
                          base salary. The Compensation Committee will be the evaluator of Employee performance and will make the final
                          decision on the bonus amount. Bonus payout will range from 0% to 50% of base salary, or at the Board’s
                          discretion, a higher percentage based on performance. Any bonus payments made under this Section 4(b) shall
                          be paid within 2 1/2 months of the end of the bonus period, provided that Employee was employed by the Company
                          on the last day of the bonus period.
	 	 	 
	 	 	Employee shall be eligible to receive a pro-rated
bonus for the portion of 2022 during which he is employed by the Company.
	 	 	 
	 	 	Employee will also be eligible to participate in a long-term
incentive plan to be adopted and maintained by the Compensation Committee, with the current long-term incentive plan attached to this
Agreement as Exhibit A.
	 	 	 
	 	 	Employee will also be considered for stock option awards in connection
with grants to key employees and in other appropriate circumstances.
	 	 	 
	 	 	Any grants of equity awards, including those above, will be made
from the Company’s Amended and Restated 2012 Stock Incentive Plan (the “2012 Plan”) or successor plans. There must be
sufficient shares available under the plan reserve for any of these grants, meaning that some of these grants may be subject to obtaining
shareholder approval of an increase to the plan reserve.















 


 






    2


     


    










 










		c.	Directors & Officers Insurance. While employed by the Company, Employee shall be considered
an officer of the Company and shall be covered by D&O Insurance, or any other similar type of insurance, that provides coverage for
Employee’s acts or omissions undertaken during the course and scope of Employee’s employment, and maintain coverage for Employee
for at least three (3) years following Employee’s employment.



 


5.                 
Additional Benefits.


 


		a.	Automobile. The Company shall reimburse Employee for deductible automobile mileage according to
its Expense Reporting Procedures.
	 	 	 
	 	b.	Business Expenses. The Company will reimburse Employee for all reasonable,
                          deductible and substantiated business expenses per its Expense Reporting Procedures. This includes, but is
                          not limited to, such expenses as computer and necessary software, cell phones and business meetings.
	 	 	 
		c.	Paid Time Off. Employee shall be entitled to thirty-three (33) days of paid time off per each calendar
year earned ratably over each calendar year, to be taken at such times as Employee and the Company shall determine and provided that no
paid time off time shall unreasonably interfere with the duties required to be rendered by Employee hereunder. Pursuant to the Company’s
policy, Employee may carry over up to a maximum of 80 hours of paid time off to the next calendar year. Accrued but unused paid time off
will be paid out to Employee at the time of termination of employment.
	 	 	 
	 	d.	Benefits. Employee will be eligible
to participate in other benefits programs generally available to executive officers of the Company specifically including health and dental
insurance, short-term and long-term disability insurance, life insurance and the 401(k) plan.



 








6.                 
Non-Competition. Employee agrees that while employed by the Company and for a period of twelve (12) months after the date Employee’s
employment with the Company terminates, regardless of the reason for termination, Employee will not, without the prior written consent
of the Company, directly or indirectly, as an employee, owner, consultant or in any other capacity whatsoever, for Employee’s own
behalf or on behalf of any other person or entity, anywhere in the United States of America:


 


		a.	Prohibition on Competition. Engage in or render services, directly or indirectly, to any person
or organization engaged in or about to become engaged in the development, production, marketing or selling of any product, process or
service in existence or under development which is similar to or competes with a product, process or service of the Company; or
	 	 	 
	 	b.	Company Clients. Work or perform services as an employee, agent, independent
                          contractor or otherwise, for any client, customer, supplier or business partner of the Company with whom Employee
                          worked, solicited, marketed or obtained confidential information about during Employee’s employment with
                          the Company; or



 





 






    3


     


    

 


		c.	Non-Solicitation. (i) Solicit, contact, sell to, provide services to, or attempt to divert, take
away or induce clients or prospective clients of the Company with whom Employee worked, solicited, marketed, or obtained confidential
information about during Employee’s employment with the Company, regarding services or products that are competitive with any of
the Company’s services or products; or (ii) solicit, divert, take away or induce any employee or independent contractor of the Company
to leave the employ or service of the Company.



 


The Company is providing Employee with adequate and valuable
consideration to compensate Employee for the reasonable restrictions on Employee’s post-employment competitive activities contained
within this Agreement. Employee hereby acknowledges that Employee’s employment with the Company, and the benefits associated with
that, the Employee’s stock option grant and access to certain of the Company’s proprietary information and goodwill, constitute
adequate and sufficient consideration for the restrictive covenants in this Agreement. Employee agrees that the restrictions set forth
in this Agreement are reasonable considering Employee’s position.


 


If any of the above restrictions are deemed by a court of competent
jurisdiction to be unreasonable in duration or in geographical scope, it will be considered modified and valid for such duration and geographical
scope as the court determines to be reasonable under the circumstances. The duration of the above restrictions will be extended beyond
the twelve (12) month period for a period equal to the duration of any breach or default of such covenant by Employee. Upon terminating
employment with the Company (for whatever reason), Employee has an affirmative obligation to inform any prospective employer and/or actual
employer, of Employee’s post-employment obligations contained within this Agreement including Employee’s non-competition and
non-solicitation obligations.


 


7.                 
Intellectual Property. Employee agrees that all rights, title and interest of every kind and nature whatsoever, whether now
known or unknown, in and to any “Intellectual Property,” defined to include, but not be limited to, any patent rights, trademarks,
copyrights, ideas, creations and properties invented, created, written, developed, furnished, produced or disclosed by Employee in the
course of rendering his/her services to the Company (both before the execution of this Agreement and thereafter) shall, as between the
Parties, be and remain the sole and exclusive property of the Company for any and all purposes and uses whatsoever, and Employee shall
have no right, title or interest of any kind or nature therein or thereto, or in and to any results and proceeds there from. Employee
agrees to assign, and hereby expressly and irrevocably assigns, to the Company all worldwide rights, title and interest, in perpetuity,
in respect of any and all rights Employee may have or acquire in the Intellectual Property. The assignment of the rights as above shall
not lapse if the Company has not exercised its rights under the assignment for any period of time or in any jurisdiction or territory.
Pursuant to Section 181.78 of the Minnesota Statutes, the preceding sentence does not apply to an invention for which no equipment, supplies,
facility or trade secret information of the Company was used and which was developed entirely on the Employee’s own time, and (1)
which does not relate (a) directly to the business of the Company or (b) to the Company’s actual or demonstrably anticipated research
or development, or (2) which does not result from any work performed by Employee for the Company. To the extent any of the rights, title,
and interest in and to the Intellectual Property cannot be assigned to the Company (and to the extent any of Employee’s retained
rights under Section 181.78 were incorporated by Employee (directly or indirectly) in any of the Company’s past, current or future
products or services), Employee hereby grants to the Company an exclusive, royalty-free, transferable, perpetual, irrevocable, unrestricted,
worldwide license (with rights to sublicense through one or more tiers of sublicense) to such non-assignable (or non-assigned) rights.
To the extent any rights, title and interest in and to Intellectual Property rights can be neither assigned nor so licensed by Employee
to the Company, Employee hereby irrevocably waives and agrees never to assert such non-assignable and non-licensable rights, title and
interest against the Company, any of the Company’s successors in interest, and the customers and licensees of either. Further, Employee
agrees to waive, and hereby waives, any “moral rights” Employee may have or may obtain in the Intellectual Property. Employee
further agrees to assist the Company in every proper way to apply for, obtain, perfect and enforce rights in the Intellectual Property
in any and all countries, and to that end Employee will execute all documents for use in applying for, obtaining and perfecting such rights
and enforcing same, as the Company may desire, together with any assignments thereof to the Company or persons designated by it. Employee
appoints the Company as its attorney in fact to execute any documents necessary to achieve such results. To the maximum extent possible,
the Company shall be shown in all documentation as the owner of all rights in the Intellectual Property.


 









    4


     


    

 


8.                 
Nondisclosure of Confidential
Information. Employee shall keep confidential and not disclose to anyone or use, either during or after Employee’s
employment with the Company, any Confidential Information of the Company, except as required by Employee’s employment with the
Company or as expressly authorized in writing by the Company. For the purposes of this Agreement, “Confidential
Information” is any and all sensitive, confidential, proprietary and trade secret information concerning or relating to the
Company and its direct and indirect parents, subsidiaries and/or affiliated organizations, including any information or compilation
of information which derives independent economic value from not being generally known to and not being readily ascertainable by
proper means by other persons who can obtain economic value from its disclosure or use. Examples of Confidential Information not to
be disclosed or used except as expressly permitted by the Company include, but are not limited to, the following:


 


		a.	All patterns, compilations, programs, know how; designs, processes or formulae; software; market or sales
information or plans, devices, methods, concepts, techniques, processes, source codes, data capture innovations, algorithms, user interface
designs and database designs relating to the Company’s products, services, systems or business;
	 	 	 
	 	b.	Information acquired or compiled by the
Company concerning actual or potential clients/customers, suppliers and business partners, including their identities, financial information
concerning their actual or prospective business operations, identity and quantity of services and/or products provided by the Company,
and any unpublished written materials furnished by or about them to the Company; and



 










		c.	Information concerning the Company’s ownership, management, financial condition, financial operations,
business activities or practices, sales activities, marketing activities or plans, research and development, pricing practices, legal
matters, and strategic business plans.



 


 






    5


     


    

 


Employee acknowledges that the Company shall at all times be
and remain the owner of all Confidential Information disclosed to/acquired by Employee during Employee’s employment with the Company,
and Employee acknowledges that Employee may use the Confidential Information only for the limited purposes for which it was disclosed
under this Agreement. Employee shall use his/her best efforts to preserve the confidentiality of such Confidential Information which he/she
knows or reasonably should know the Company deems to be Confidential Information. Employee agrees that he/she will not knowingly use,
disclose or permit the use or disclosure of the Company’s Confidential Information in any manner which may injure the Company’s
business, impair its investments and goodwill, and/or adversely impact the Company’s relationships with its actual or potential
customers and suppliers. The obligations of this Section shall continue in full force and effect after the termination of this Agreement
and the termination of Employee’s employment with the Company. As used in this Section 8, the “Company” shall include
the Company and each of its direct and indirect parent, subsidiary and affiliated organizations on a collective basis.


 


9.                 
Use, Removal, and Return of the Company’s Property. Employee shall not use, duplicate, disseminate or remove from the
Company’s premises any information contained in any records, documents, data, or other tangible items of the Company in original,
duplicate or copied form, except as needed in the ordinary course of performing his/her employment duties for and subject to the approval
by the Company. Employee shall immediately deliver to the Company, upon termination of Employee’s employment with the Company, or
at any other time upon the Company’s request, any records, documents, data, and other tangible items in Employee’s possession
or control belonging to or relating to the products, services, systems or business of the Company. Employee will not retain any copies
or reproductions of records, documents, data or other tangible items of the Company or any of its direct or indirect parent, subsidiary
or affiliated organizations.


 


10.              
Termination by Company for Cause. The Company may terminate Employee’s employment for “Cause” at any time,
without notice. For purposes of this Agreement, the term “Cause” shall mean any of the following:


 


		·	Employee engages in willful misconduct or fails to follow the reasonable and lawful instructions of the
Board of Directors, if such conduct is not cured within thirty (30) calendar days after the Company sends notice to the Employee of the
alleged Cause,



 


		·	Employee embezzles or misappropriates assets of the Company or any of its subsidiaries;



 


		·	Employee’s violation of Employee’s obligations in this Agreement, if such conduct is not cured
within thirty (30) calendar days after the Company sends written notice to the Employee of the alleged Cause;



 


 






    6


     


    

 


		·	Breach of any agreement between Employee and the Company or to which the Company and Employee are parties,
or a breach by Employee of a fiduciary duty or responsibility to the Company;



 


		·	The commission by Employee of fraud or other willful conduct that adversely affects the business or reputation
of the Company, as determined in the Company’s sole discretion; or,



 


		·	The Company has a reasonable belief Employee engaged in some form of harassment or other improper conduct
prohibited by the Company policy or the law.



 


In the event of a termination for Cause, Employee shall only
be entitled to receive payment of base salary, in effect at the time of termination, through Employee’s last date of employment
and accrued, unused paid time off. Employee will not be entitled to any other payments, salary or bonus. Employee shall have absolutely
no right to receive or retain any other payment or compensation whatsoever under this Agreement. The Employee’s rights and obligations
regarding stock options, restricted stock or other equity incentives owned by Employee shall be determined in accordance with and be governed
by the 2012 Plan or other applicable equity plan.


 


11.                 
Termination by the Company without Cause. The Company may terminate Employee’s employment without Cause at any time,
for any reason, without notice. In the event Employee’s employment is terminated by the Company without Cause, Employee shall be
entitled to receive payment of base salary, in effect at the time of termination, through Employee’s last date of employment and
accrued, unused paid time off. In addition, Employee shall be entitled to receive from the Company (a) severance pay in an amount equal
to twelve (12) months of Employee’s base salary then in effect at the time of termination, less applicable taxes and withholdings;
and (b) bonus payment on a pro-rata basis through the date of Employee’s termination. The severance pay and bonus payment provided
in the preceding sentence is conditioned upon Employee’s execution of a full and final waiver of all claims against the Company,
and not rescinding or revoking (to the extent permitted under such release) Employee’s release, in a form acceptable to the Company.
The severance pay and bonus payment will be paid to Employee in equal bimonthly installments over a period of 12 (twelve) months (or 24
pay periods), with the first payment on the first payday following Employee’s execution of the release and the expiration of any
rescission and revocation periods provided in the release and subsequent payments on subsequent paydays.


 


12.                
 Termination by Employee for Good
Reason. For purposes of this Agreement, “Good Reason” shall include (i) a material diminution in Employee’s
position, duties, base salary, and responsibilities; or (ii) the Company’s notice to Employee that his or her position will be
relocated to an office which is greater than 100 miles from Employee’s prior office location. In all cases of Good Reason,
Employee must have given notice to the Company that an alleged Good Reason event has occurred and the circumstance must remain
uncorrected by the Company after the expiration of thirty (30) days after receipt by the Company of such notice. If Employee
terminates his or her employment for Good Reason, Employee shall be entitled to receive from the Company payment of base salary, in
effect at the time of termination, through Employee’s last date of employment and accrued, unused paid time off. In addition,
Employee shall be entitled to (a) severance pay in an amount equal to twelve (12) months of Employee’s base salary then in
effect at the time of termination, less applicable taxes and withholdings; and (b) bonus payment on a pro-rata basis through the
date of Employee’s termination. The severance pay and bonus payment provided in the preceding sentence is conditioned upon
Employee’s execution of a full and final waiver of all claims against the Company, and not rescinding or revoking (to the
extent permitted under such release) Employee’s release, in a form acceptable to the Company. The severance pay and bonus
payment will be paid to the Employee in equal bimonthly installments over a period of 12 (twelve) months (or 24 pay periods) with
the first payment on the first payday following Employee’s execution of the release and the expiration of any rescission and
revocation periods provided in the release and subsequent payments on subsequent paydays.


 


 






    7


     


    

 


13.                 
Termination by Employee without Good Reason. If Employee terminates his or her employment with the Company without Good Reason,
Employee is only entitled to his or her base salary, then in effect at the time of termination, through Employee’s last day of employment
and accrued, unused paid time off. Employee will not be entitled to any other payments, salary, or bonus.


 


14.                 Governing Law; Venue. This Agreement
shall be governed by and construed in accordance with the laws of the State of Minnesota. The venue for any action relating to this
Agreement shall be the federal or state courts located in Dakota County, Minnesota, to which venue each party hereby submits.


 


15.                 
Notices. Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed to have
been given, when received, if delivered by hand or by telegram, or three (3) working days after deposited, if placed in the mail for delivery
by certified mail, return receipt requested, postage prepaid and addressed to the appropriate party at the following addresses:


 





	Company:	Predictive Oncology Inc.

                         Attention: Bob Myers, CFO

                         2915 Commers Drive

                         Suite 900

                         Eagan, Minnesota 55121
	 
	 	 	 
	Employee:	Raymond F. Vennare

      179 West Hutchinson Avenue

      Pittsburgh, PA 15218
	 



 








Addresses may be changed by written notice given pursuant
to this Section; however, any such notice shall not be effective, if mailed, until three (3) working days after depositing in the mails
or when actually received, whichever occurs first.


 


16.             
Other Agreements. This Agreement contains the entire agreement between the Parties concerning terms of employment and supersedes
at the effective date hereof any other agreement, written or oral, except the 2012 Plan or other applicable equity plans and the applicable
award agreements under such plans.


 


 






    8


     


    

 


17.            
Modification and Waiver. A waiver by
either party of a breach of any provision of this Agreement shall not operate as or be construed as a waiver of any subsequent
breach thereof. Any modification of this Agreement must be in writing and signed by both parties.


 


18.             
Scope of Remedies. In the event Employee breaches the covenants contained in this Agreement, Employee recognizes that irreparable
injury will result to the Company, that the Company’s traditional remedies at law for damages will be inadequate, and that the Company
shall be entitled to injunctive relief ordered by a judicial court of competent jurisdiction to restrain the continuing breach by Employee,
Employee’s partners, agents, or employees, or any other persons or entities acting for or with Employee. The Company shall further
be entitled to seek remedies in a judicial court of competent jurisdiction for damages, reasonable attorney’s fees, and all other
costs and expenses incurred in connection with the enforcement of this Agreement, in addition to any other rights and remedies which the
Company may have at law or in equity.


 


19.             
Binding Effect, Assigns, Successors,
Etc. The benefits and obligations of this Agreement shall inure to the successors and assigns of the Company, to any person or entity
which purchases substantially all of the assets of the Company, and to any subsidiary, affiliated corporation, or operating division
of the Company. This Agreement is not assignable by Employee.


 


20.             
Savings Clause. If any provision, portion or aspect of this Agreement is determined to be void, or voidable by any legislative,
judicial or administrative action as properly applied to this Agreement, then this Agreement shall be construed to so limit such provision,
portion or aspect thereof to render same enforceable to the greatest extent permitted by or in the relevant jurisdiction.


 


21.             
Headings. The headings of this
Agreement are intended solely for convenience and reference, and shall give no effect in the construction or interpretation of this
Agreement.


 


22.               Survival.
The restrictions on Employee’s post-employment activities (including Employee’s confidentiality obligations and restrictive
covenants), and those sections of this Agreement that pertain to interpretation and enforcement of such restrictions, will survive the
termination of this Agreement and/or Employee’s employment and will remain in full force and effect.


 


23.             
Execution and Delivery. This Agreement
may be executed in counterparts, which taken together shall constitute one agreement binding on all the Parties. Electronically transmitted
signatures shall be valid and binding to the same extent as signatures delivered in original. In making proof of this Agreement, it will
be necessary to produce only one copy signed (or reproduced from an electronically delivered signature) by the party to be charged.


 


Signature page follows.


 


 






    9


     


    




 


IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be executed effective as of the day and year first written above.


 


 





	 	PREDICTIVE ONCOLOGY INC.	 
	 	 	 	 
	 	By: 	/s/ Bob Myers	 
	 	Title: 	CFO	 
	 	 	 	 



 








	 	EMPLOYEE	 
	 	 	 	 
	 	By:	/s/ Raymond F. Vennare	 
	 	 	Raymond F. Vennare	 
	 	 	 	 









 





 





The rest of this page is intentionally blank. 


 


Exhibit A follows on the next page. 


 


 


 






    10


     


    

 





EXHIBIT A TO EMPLOYMENT AGREEMENT


 


Long Term Incentive Plan: Employee will be granted an equity
incentive award in the form of restricted stock units (RSUs), structured to reward performance and result in officer retention. The Long-Term
Incentive Plan (“LTIP”) award will vest after three years subject to continued employment, with the amount that vests to be
based on two or more measures of employment performance, including shareholder return (increase in common stock price and accomplishment
of profit budgets), as further described below:


 


		1.	Employee will be granted 300,000 RSUs (target) on January 1, 2023 (3-year vesting), or such later time as
shareholder approval is obtained as described below.



 


		2.	The RSU award will consist of three equal tranches, corresponding to the three years in the performance period.
The RSUs will vest on January 1, 2026, with the level of vesting of each tranche based on (1) the level of achievement of performance
goals for the corresponding fiscal year (see below) and (2) continued employment of the executive through January 1, 2026. For each tranche,
the RSUs will vest at the 100% level for performance at the target level; 50% for performance at the threshold level (with no vesting
below the threshold level); and 150% for maximum performance (in other words, for maximum performance on both performance components in
a fiscal year, the payout for that year would be 150% of the number of RSUs (target) in the corresponding tranche). The level of vesting
for each component will be prorated between the threshold level and the target level, and between the target level and the maximum level,
as applicable. To the extent vested, the awards will be paid out in shares of common stock on or before March 15, 2026, following the
determination of the Company’s earnings per share in 2025.



 


The LTIP will be governed by an RSU agreement and the RSUs will granted
from the Company’s Amended and Restated 2012 Stock Incentive Plan (the “2012 Plan”) or successor plans. There must be
sufficient shares available under the plan reserve for the grant, meaning that the grant may be subject to obtaining shareholder approval
of an increase to the plan reserve. There are currently only 1,004,599 shares available under the 2012 Plan, meaning that the grant of
the award described above may not be made until shareholders approve an amendment to the 2012 Plan to increase the share reserve or approve
a successor plan with sufficient reserved shares . If shareholder approval is necessary for the RSU award described above and is not obtained
prior to expiration of the performance period, the Company may grant a cash award of equivalent value.


 


 


 


 


 


 


 


 


 


 


 


11